Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Nov 21, 2006; 12(43): 6992-6997
Published online Nov 21, 2006. doi: 10.3748/wjg.v12.i43.6992
Published online Nov 21, 2006. doi: 10.3748/wjg.v12.i43.6992
Characteristics | TACE + LT group (n = 36) | LT group (n = 21) | P |
Age (yr) | 49 ± 8.2 | 52 ± 8.0 | 0.13 |
Sex (M/F) | 31/5 | 18/3 | 0.99 |
Etiology of liver disease | 0.12 | ||
HBV | 34 (94.4%) | 18 (85.7%) | |
HCV | 0 (0%) | 2 (9.5%) | |
HBV + HCV | 1 (2.8%) | 0 (0%) | |
Alcoholic | 0 (0%) | 1 (4.8%) | |
α-fetoprotein (µg/L) | 193 ± 472 | 1012 ± 4110 | 0.24 |
TACE | |||
1 | 12 (33.3%) | - | |
2 | 16 (44.4%) | - | |
≥ 3 | 8 (22.2%) | - | |
MELD score | 19 ± 9 | 22 ± 9 | 0.10 |
Type of graft | |||
Cadaveric graft | 8 (22.2%) | 2 (9.5%) | 0.30 |
Living graft | 28 (77.8%) | 19 (90.5%) | |
Number of nodules | |||
1/2/3 | 24/6/6 | 18/2/1 | 0.26 |
Diameter of the largest tumor (cm) | 0.10 | ||
Mean ± SD | 2.0 ± 0.6 | 2.3 ± 0.9 | |
Range | 0.9-4.0 | 1.0-4.0 | |
Sum of the tumor diameters (cm) | 0.38 | ||
Mean ± SD | 2.5 ± 1.1 | 2.8 ± 1.3 | |
Range (cm) | 0.9-6.1 | 1.0-5.9 |
Variable | TACE + LT group (n = 36) | LT group (n = 21) | P |
Number of nodules | |||
1/2/3/≥4 | 18/8/3/7 | 13/3/3/2 | 0.79 |
Diameter of the largest tumor (cm) | |||
Mean ± SD | 2.5 ± 1.4 | 2.3 ± 0.9 | 0.70 |
Range | 0.6-7.5 | 0.5-4.2 | |
Sum of the tumor diameters (cm) | |||
Mean ± SD | 3.8 ± 2.6 | 3.3 ± 1.3 | 0.36 |
Range | 0.6-14.0 | 0.5-7.0 | |
Tumor differentiation1 | 0.59 | ||
Edmonson gradeI | 5 (16.7%) | 6 (28.6%) | |
II | 22 (73.3%) | 13 (61.9%) | |
III | 3 (10%) | 2 (9.5%) | |
Presence of satellite nodule | 5 (13.9%) | 2 (9.5%) | 0.99 |
Tumor capsule invasion | 11 (30.6%) | 3 (14.3%) | 0.21 |
Microvascular invasion | 11 (30.6%) | 9 (42.9%) | 0.40 |
Patient | Group | Time to recur (mo) | Site of recur | Treatment after recurrence | Survival (mo) |
1 | TACE + LT | 9.6 | Liver | None | 10.0 |
2 | TACE + LT | 3.3 | Liver, bone | TACE | 7.1 |
3 | LT | 15.4 | Lymph node | Excision, TACE | 21.0 |
4 | TACE + LT | 0.9 | Lung, liver | TACE | 5.7 |
- Citation: Kim DY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC, Shin SW, Choo SW, Do YS, Rhee JC. Milan criteria are useful predictors for favorable outcomes in hepatocellular carcinoma patients undergoing liver transplantation after transarterial chemoembolization. World J Gastroenterol 2006; 12(43): 6992-6997
- URL: https://www.wjgnet.com/1007-9327/full/v12/i43/6992.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i43.6992